Regulation of Articular Cartilage Zonal Emergence: Harnessing Developmental Pathways to Enhance Regeneration
ReZone aims to uncover the mechanisms of zonal emergence in articular cartilage using a goat model to enhance regeneration and improve treatment for cartilage injuries.
Projectdetails
Introduction
Articular cartilage (AC) has a complex zonal structure and composition, providing it with its essential functional properties. However, when cartilage is damaged, the zonal complexity does not regenerate, leaving an inferior tissue that is prone to degeneration. As a result, cartilage injury commonly leads to pain and the eventual need for joint replacement.
Background
Progress towards true regeneration of AC requires an advance in understanding how zonal complexity (and corresponding function) emerge over development. The most promising clue to understanding zonal emergence is that mechanical forces are known to be important for normal AC development.
Project Overview
ReZone will reveal the mechanisms underlying zonal emergence through a novel goat model in which a common veterinary procedure is repurposed to create a radically altered mechanical environment in the developing joint.
Methodology
By comparing gene activity between normal and altered states of zonal emergence, I will identify pathways likely to be involved in zonal emergence. I will leverage my expertise in cartilage explant culture and mechanostimulation bioreactors to develop a novel in vitro explant model, and use this model to validate candidate pathways.
Therapeutic Potential
Finally, I will demonstrate the therapeutic potential of molecular regulators of zonal emergence using gene-activated biomaterials to regenerate zonal emergence in an in vivo, large-animal model of cartilage repair.
Expected Outcomes
ReZone will provide a step-change in our understanding of how zonal AC develops postnatally, including the role of mechanical loading. The project’s ambitious aim is to bring about enhanced regeneration of AC through activation of the developmental processes which form functional cartilage in early life.
Conclusion
Revealing key mechanisms underlying zonal emergence in immature AC will enable true regeneration of injured AC, improving the quality of life for patients with articular cartilage defects worldwide.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.265.746 |
Totale projectbegroting | € 2.265.746 |
Tijdlijn
Startdatum | 1-6-2024 |
Einddatum | 31-5-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Restoring the structural collagen network in the regeneration of cartilageRe-COLL aims to develop durable implants for damaged joints by engineering anisotropic collagen networks through biofabrication and in vitro models, enhancing tissue regeneration and stability. | ERC Advanced... | € 2.500.000 | 2024 | Details |
ENGINEERING CELLULAR SELF‐ORGANISATION BY CONTROLLING THE IMMUNO-MECHANICAL INTERPLAYThis project aims to reduce scarring in bone regeneration by engineering synthetic immune-mechanical niches to enhance cell self-organization and matrix formation, improving healing outcomes. | ERC Advanced... | € 2.490.725 | 2023 | Details |
Mechanisms and consequences of cell state transitions during heart regenerationThis project aims to uncover the coordinated cellular responses in zebrafish heart regeneration post-injury using single-cell genomics and computational methods to enhance understanding of organ repair mechanisms. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Rewiring gene regulatory circuits to enhance central nervous system repairThis project aims to rewire gene expression in mammalian neural stem cells using synthetic enhancers to promote regeneration after CNS injury, enhancing cell replacement and gene therapy strategies. | ERC Starting... | € 1.500.000 | 2023 | Details |
Tight junctions and tissue mechanics as sensors and executers of heart regenerationThis project aims to understand salamander regeneration by integrating gene editing, imaging, and mechanical analysis to explore tight junctions' role in cellular responses and regeneration control. | ERC Starting... | € 2.318.778 | 2025 | Details |
Restoring the structural collagen network in the regeneration of cartilage
Re-COLL aims to develop durable implants for damaged joints by engineering anisotropic collagen networks through biofabrication and in vitro models, enhancing tissue regeneration and stability.
ENGINEERING CELLULAR SELF‐ORGANISATION BY CONTROLLING THE IMMUNO-MECHANICAL INTERPLAY
This project aims to reduce scarring in bone regeneration by engineering synthetic immune-mechanical niches to enhance cell self-organization and matrix formation, improving healing outcomes.
Mechanisms and consequences of cell state transitions during heart regeneration
This project aims to uncover the coordinated cellular responses in zebrafish heart regeneration post-injury using single-cell genomics and computational methods to enhance understanding of organ repair mechanisms.
Rewiring gene regulatory circuits to enhance central nervous system repair
This project aims to rewire gene expression in mammalian neural stem cells using synthetic enhancers to promote regeneration after CNS injury, enhancing cell replacement and gene therapy strategies.
Tight junctions and tissue mechanics as sensors and executers of heart regeneration
This project aims to understand salamander regeneration by integrating gene editing, imaging, and mechanical analysis to explore tight junctions' role in cellular responses and regeneration control.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Rebuilding Joint Surface to Prevent Pain and ImmobilityAskel's COPLA® implant promotes cartilage regeneration and quick rehabilitation to prevent osteoarthritis, aiming to establish a gold standard for pain-free joint movement and improved quality of life. | EIC Accelerator | € 2.499.000 | 2022 | Details |
NCM for osteoarthritisNC Biomatrix onderzoekt een innovatieve therapie voor artrose met notochordale cellen om pijn aan te pakken en kraakbeen te herstellen. | Mkb-innovati... | € 20.000 | 2021 | Details |
SyCap MechanoAvalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten. | Mkb-innovati... | € 20.000 | 2022 | Details |
Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cordPiezo4Spine aims to create a groundbreaking 3D bioprinted mesh therapy for spinal cord injury that enhances neural repair through targeted mechanotransduction and gene therapy. | EIC Pathfinder | € 3.537.120 | 2023 | Details |
Development of a Complete Triple Action Injectable Treatment for OsteoarthritisRelevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients. | EIC Transition | € 2.398.115 | 2022 | Details |
Rebuilding Joint Surface to Prevent Pain and Immobility
Askel's COPLA® implant promotes cartilage regeneration and quick rehabilitation to prevent osteoarthritis, aiming to establish a gold standard for pain-free joint movement and improved quality of life.
NCM for osteoarthritis
NC Biomatrix onderzoekt een innovatieve therapie voor artrose met notochordale cellen om pijn aan te pakken en kraakbeen te herstellen.
SyCap Mechano
Avalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten.
Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cord
Piezo4Spine aims to create a groundbreaking 3D bioprinted mesh therapy for spinal cord injury that enhances neural repair through targeted mechanotransduction and gene therapy.
Development of a Complete Triple Action Injectable Treatment for Osteoarthritis
Relevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients.